Immunomedics (IMMU) Misses Q3 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Immunomedics (IMMU) Misses Q3 EPS by 9c

Immunomedics Reports Third Quarter 2019 Results and Provides Corporate Update

October 30, 2019 4:01 PM EDT

TROPHY-U-01 Reached Target Enrollment in Cisplatin-Eligible Cohort of 100 Patients

First NSCLC Patient Dosed in Trop-2-Enriched TROPiCS-03 Study

BLA Resubmission Targeted for Late November/Early December 2019

MORRIS PLAINS, N.J., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (Immunomedics or the Company), a leading biopharmaceutical company in... More